Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: 3 Biotech Stocks That Will Be Making Big Moves

"I will do my part"

Just curious. Are there groups out there, including physicians, taking up the cause? This has been a successful lobbying tactic in the past. With all the focus on preventitive measures to save long term cost and focus on outcomes, you would think Afrezza would be a strong rallying point for diabetics that need this therapy. You are a big group.

Share
New Message
Please login to post a reply